Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Aug;14(8):1259-62.
doi: 10.3201/eid1408.071059.

Increased amoxicillin-clavulanic acid resistance in Escherichia coli blood isolates, Spain

Jesús Oteo  1 , José Campos, Edurne Lázaro, Oscar Cuevas, Silvia García-Cobos, María Pérez-Vázquez, F J de Abajo; Spanish Members of EARSS
Collaborators, Affiliations

Increased amoxicillin-clavulanic acid resistance in Escherichia coli blood isolates, Spain

Jesús Oteo et al. Emerg Infect Dis. 2008 Aug.

Abstract

To determine the evolution and trends of amoxicillin-clavulanic acid resistance among Escherichia coli isolates in Spain, we tested 9,090 blood isolates from 42 Spanish hospitals and compared resistance with trends in outpatient consumption. These isolates were collected by Spanish hospitals that participated in the European Antimicrobial Resistance Surveillance System network from April 2003 through December 2006.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Evolution of amoxicillin-clavulanic acid nonsusceptibility of Escherichia coli from blood isolates, Spain, 2003–2006. ESBL, extended-spectrum β-lactamase.
Figure 2
Figure 2
Evolution of consumption of outpatient penicillin/β-lactamase inhibitors (World Health Organization code J01CR02), Spain, 2000–2006. DDD, defined daily dose.
See this image and copyright information in PMC

References

    1. Oteo J, Lázaro E, de Abajo FJ, Baquero F, Campos J. Spanish members of EARSS. Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis. 2005;11:546–53. - PMC - PubMed
    1. Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997–1998. Clin Infect Dis. 2000;30:454–60. 10.1086/313710 - DOI - PubMed
    1. Lark RL, Saint S, Chenoweth C, Zemencuk JK, Lipsky BA, Plorde JJ. Four-year prospective evaluation of community-acquired bacteremia: epidemiology, microbiology and patient outcome. Diagn Microbiol Infect Dis. 2001;41:15–22. 10.1016/S0732-8893(01)00284-X - DOI - PubMed
    1. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579–87. - PubMed
    1. Lázaro BE, Madurga SM, de Abajo FJ. Evolución del consumo de antibióticos en España, 1985–2000. Med Clin (Barc). 2002;118:561–8. - PubMed

Publication types

Substances